⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockGermanyXETRA

BAYN.DE

Bayer Aktiengesellschaft

Healthcare · Drug Manufacturers - General

49.26EUR

-0.1500 (-0.30%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(EUR)202220232024202520262027
FY50.7B47.6B46.6B45.6B45.8B47.0B
Q1————13.4B—
Q2———10.7B10.9B—
Q3———9.7B9.9B—
Q4———11.4B11.7B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(EUR)202220232024202520262027
FY4.22-2.99-2.60-3.684.544.83
Q1———1.322.81—
Q2———-.200.230—
Q3———-.980.435—
Q4——

Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

—
-3.82
.406
—